WuXi Biologics (Cayman) Inc. (HKG:2269)

WuXi Biologics Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 13, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	94,028	72,100	124,993	252,882	390,943	419,914
Market Cap Growth	-42.32%	-42.32%	-50.57%	-35.32%	-6.90%	228.81%
Enterprise Value	91,781	71,052	122,776	247,673	380,146	418,224
Last Close Price	23.15	17.56	29.60	59.85	92.55	102.80
PE Ratio	27.72	20.19	33.37	50.61	93.99	209.36
Forward PE	19.69	17.09	22.71	37.41	77.91	168.15
PS Ratio	4.73	3.63	6.66	14.65	30.95	63.00
PB Ratio	1.94	1.49	2.58	6.18	9.74	16.92
P/TBV Ratio	2.22	1.70	2.96	6.79	10.56	17.69
P/FCF Ratio	68.62	52.62	182.37	-	-	-
P/OCF Ratio	16.94	12.99	24.31	40.37	92.82	187.95
PEG Ratio	1.26	1.99	1.39	1.02	1.99	3.92
EV/Sales Ratio	4.62	3.58	6.54	14.35	30.10	62.75
EV/EBITDA Ratio	14.32	11.42	22.61	43.22	85.50	198.82
EV/EBIT Ratio	18.81	14.56	28.34	50.36	97.69	234.41
EV/FCF Ratio	66.98	51.85	179.13	-	-	-
Debt / Equity Ratio	0.11	0.11	0.10	0.12	0.13	0.16
Debt / EBITDA Ratio	0.82	0.82	0.89	0.86	1.18	1.85
Debt / FCF Ratio	3.84	3.84	7.33	-	-	-
Asset Turnover	0.33	0.33	0.32	0.33	0.28	0.24
Inventory Turnover	6.71	6.71	5.04	4.31	3.94	4.15
Quick Ratio	1.98	1.98	2.35	1.56	1.85	2.49
Current Ratio	2.73	2.73	2.78	1.98	2.37	3.16
Return on Equity (ROE)	8.82%	8.82%	8.90%	13.20%	13.09%	10.02%
Return on Assets (ROA)	5.05%	5.05%	4.63%	5.81%	5.43%	4.03%
Return on Capital (ROIC)	5.79%	5.79%	5.51%	7.00%	6.47%	4.78%
Return on Capital Employed (ROCE)	9.50%	9.50%	8.00%	10.80%	8.90%	6.10%
Earnings Yield	3.80%	4.95%	3.00%	1.98%	1.06%	0.48%
FCF Yield	1.46%	1.90%	0.55%	-0.15%	-0.97%	-1.17%
Buyback Yield / Dilution	2.80%	2.80%	0.62%	1.04%	-5.05%	-5.30%

Updated Sep 20, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.